(0.25%) 5 167.75 points
(0.22%) 38 916 points
(0.23%) 18 043 points
(1.19%) $79.04
(0.28%) $2.15
(0.91%) $2 329.60
(2.72%) $27.42
(1.29%) $977.80
(-0.03%) $0.929
(-0.23%) $10.85
(-0.25%) $0.795
(0.01%) $91.46
Live Chart Being Loaded With Signals
Vectura Group Plc engages in the provision of pharmaceutical development. The company is headquartered in Chippenham, Wiltshire and currently employs 453 full-time employees...
Stats | |
---|---|
本日の出来高 | 203 762 |
平均出来高 | 8.30M |
時価総額 | 0.00 |
EPS | £-0.00834 ( 2019-06-29 ) |
Last Dividend | £19.00 ( 2021-06-01 ) |
Next Dividend | £0 ( N/A ) |
P/E | 0.0800 |
ATR14 | £0 (0.00%) |
Vectura Group PLC 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Vectura Group PLC 財務諸表
Annual | 2020 |
収益: | £190.60M |
総利益: | £101.40M (53.20 %) |
EPS: | £0.188 |
FY | 2020 |
収益: | £190.60M |
総利益: | £101.40M (53.20 %) |
EPS: | £0.188 |
FY | 2019 |
収益: | £178.30M |
総利益: | £95.30M (53.45 %) |
EPS: | £-0.0340 |
FY | 2018 |
収益: | £160.50M |
総利益: | £98.90M (61.62 %) |
EPS: | £-0.143 |
Financial Reports:
No articles found.
Vectura Group PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
First Dividend | £6.50 | 2019-10-14 |
Last Dividend | £19.00 | 2021-06-01 |
Next Dividend | £0 | N/A |
Payout Date | 2021-06-11 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | £25.50 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.69 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.35 | |
Div. Directional Score | 8.24 | -- |
Year | Amount | Yield |
---|---|---|
2019 | £0 | 0.00% |
2020 | £0 | 0.00% |
2021 | £0 | 0.00% |
2022 | £0 | 0.00% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SPX.L | Dividend Knight | 2023-10-12 | Semi-Annually | 32 | 0.67% | |
JARA.L | Dividend Knight | 2023-08-03 | Quarterly | 5 | 2.54% | |
BSIF.L | Dividend Knight | 2023-08-17 | Quarterly | 11 | 3.73% | |
PMI.L | Dividend King | 2023-07-06 | Semi-Annually | 8 | 4.24% | |
FRAN.L | Dividend Knight | 2023-09-14 | Semi-Annually | 8 | 0.75% | |
ABD.L | Dividend Knight | 2023-08-10 | Semi-Annually | 35 | 0.96% | |
THRL.L | Dividend King | 2023-08-10 | Quarterly | 12 | 3.80% | |
LIO.L | Dividend Royal | 2023-06-29 | Semi-Annually | 24 | 261.80% | |
CLDN.L | Dividend Knight | 2023-06-29 | Semi-Annually | 21 | 1.73% | |
RICO.L | Dividend Knight | 2023-09-28 | Semi-Annually | 17 | 1.55% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.642 | 1.500 | 10.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.184 | 1.200 | 3.87 | 4.65 | [0 - 0.3] |
returnOnEquityTTM | 0.254 | 1.500 | 8.29 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 3.59 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 0.923 | 0.800 | 9.28 | 7.42 | [0.8 - 2.5] |
cashRatioTTM | 0.923 | 1.500 | 5.99 | 8.98 | [0.2 - 2] |
debtRatioTTM | 0.00631 | -1.500 | 9.89 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 1 314.00 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0380 | 2.00 | 9.99 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0181 | 2.00 | 9.99 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.00771 | -1.500 | 9.97 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.532 | 1.000 | 4.47 | 4.47 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.689 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 5.90 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.286 | 0.800 | -1.425 | -1.140 | [0.5 - 2] |
Total Score | 12.14 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 8.78 | 1.000 | 9.21 | 0 | [1 - 100] |
returnOnEquityTTM | 0.254 | 2.50 | 8.90 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0181 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0380 | 2.00 | 9.99 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.130 | 1.000 | 9.25 | 0 | [0.1 - 0.5] |
Total Score | 4.35 |
Vectura Group PLC
Vectura Group Plc engages in the provision of pharmaceutical development. The company is headquartered in Chippenham, Wiltshire and currently employs 453 full-time employees. The firm's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) - LABA-LAMA; Seebri Breezhaler (EU and RoW) - LAMA; AirFluSal Forspiro (EU and RoW) - ICS-LABA; ADVATE (Global) - Antihaemophilic Factor (Recombinant); Adept (Global) - Icodextrin; Anoro Ellipta (Global) - LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) - ICS-LABA, and Incruse Ellipta (Global) - LAMA. Its product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465. Its dry powder inhalers (DPI) include GyroHaler, Lever-operated, Open-inhale-close and Unit Dose DPI. Its smart nebuliser delivery systems provide targeted inhalation therapy for applications where precise and targeted delivery of a drug to the lungs is needed. Its smart nebulizer delivery systems include AKITA JET and FOX.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。